- Home
- KORE vs MAIA Comparison
KORE vs MAIA Comparison
Compare KORE & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KORE
- MAIA
- Stock Information
- Founded
- KORE 2003
- MAIA 2018
- Country
- KORE United States
- MAIA United States
- Employees
- KORE N/A
- MAIA N/A
- Industry
- KORE Telecommunications Equipment
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- KORE Consumer Discretionary
- MAIA Health Care
- Exchange
- KORE Nasdaq
- MAIA Nasdaq
- Market Cap
- KORE 39.6M
- MAIA 46.7M
- IPO Year
- KORE N/A
- MAIA 2022
- Fundamental
- Price
- KORE $2.75
- MAIA $1.77
- Analyst Decision
- KORE Hold
- MAIA
- Analyst Count
- KORE 2
- MAIA 0
- Target Price
- KORE $2.75
- MAIA N/A
- AVG Volume (30 Days)
- KORE 11.1K
- MAIA 274.6K
- Earning Date
- KORE 05-15-2025
- MAIA 05-09-2025
- Dividend Yield
- KORE N/A
- MAIA N/A
- EPS Growth
- KORE N/A
- MAIA N/A
- EPS
- KORE N/A
- MAIA N/A
- Revenue
- KORE $282,254,000.00
- MAIA N/A
- Revenue This Year
- KORE $4.53
- MAIA N/A
- Revenue Next Year
- KORE $6.86
- MAIA N/A
- P/E Ratio
- KORE N/A
- MAIA N/A
- Revenue Growth
- KORE N/A
- MAIA N/A
- 52 Week Low
- KORE $1.10
- MAIA $1.40
- 52 Week High
- KORE $4.88
- MAIA $5.99
- Technical
- Relative Strength Index (RSI)
- KORE 56.67
- MAIA 45.28
- Support Level
- KORE $2.33
- MAIA $1.71
- Resistance Level
- KORE $2.57
- MAIA $1.85
- Average True Range (ATR)
- KORE 0.14
- MAIA 0.12
- MACD
- KORE 0.03
- MAIA -0.02
- Stochastic Oscillator
- KORE 86.79
- MAIA 12.82
About KORE KORE Group Holdings Inc.
Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates the majority of its revenue from the United States and the rest from other countries.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.